Arcus Biosciences (RCUS) Receivables - Other: 2017-2025
Historic Receivables - Other for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to $11.0 million.
- Arcus Biosciences' Receivables - Other fell 31.25% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 31.25%. This contributed to the annual value of $20.0 million for FY2024, which is 47.37% down from last year.
- Per Arcus Biosciences' latest filing, its Receivables - Other stood at $11.0 million for Q3 2025, which was down 26.67% from $15.0 million recorded in Q2 2025.
- Over the past 5 years, Arcus Biosciences' Receivables - Other peaked at $52.0 million during Q3 2023, and registered a low of -$715.0 million during Q1 2022.
- Moreover, its 3-year median value for Receivables - Other was $28.0 million (2024), whereas its average is $27.0 million.
- In the last 5 years, Arcus Biosciences' Receivables - Other skyrocketed by 1,251.99% in 2021 and then tumbled by 18,060.31% in 2022.
- Arcus Biosciences' Receivables - Other (Quarterly) stood at $17.3 million in 2021, then dropped by 19.12% to $14.0 million in 2022, then spiked by 171.16% to $38.0 million in 2023, then tumbled by 47.37% to $20.0 million in 2024, then tumbled by 31.25% to $11.0 million in 2025.
- Its Receivables - Other was $11.0 million in Q3 2025, compared to $15.0 million in Q2 2025 and $15.0 million in Q1 2025.